GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vext Science Inc (XCNQ:VEXT) » Definitions » EV-to-EBITDA

Vext Science (XCNQ:VEXT) EV-to-EBITDA : 4.91 (As of Jun. 24, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Vext Science EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Vext Science's enterprise value is C$84.86 Mil. Vext Science's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was C$17.30 Mil. Therefore, Vext Science's EV-to-EBITDA for today is 4.91.

The historical rank and industry rank for Vext Science's EV-to-EBITDA or its related term are showing as below:

XCNQ:VEXT' s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.33   Med: 7.46   Max: 43.57
Current: 4.91

During the past 7 years, the highest EV-to-EBITDA of Vext Science was 43.57. The lowest was 2.33. And the median was 7.46.

XCNQ:VEXT's EV-to-EBITDA is ranked better than
87.61% of 710 companies
in the Drug Manufacturers industry
Industry Median: 14.09 vs XCNQ:VEXT: 4.91

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-24), Vext Science's stock price is C$0.21. Vext Science's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was C$0.004. Therefore, Vext Science's PE Ratio for today is 52.50.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Vext Science EV-to-EBITDA Historical Data

The historical data trend for Vext Science's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vext Science EV-to-EBITDA Chart

Vext Science Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial 2.61 8.40 3.48 3.08 3.73

Vext Science Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.78 5.50 8.24 3.73 5.60

Competitive Comparison of Vext Science's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Vext Science's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vext Science's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vext Science's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Vext Science's EV-to-EBITDA falls into.



Vext Science EV-to-EBITDA Calculation

Vext Science's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=84.857/17.299
=4.91

Vext Science's current Enterprise Value is C$84.86 Mil.
Vext Science's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$17.30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vext Science  (XCNQ:VEXT) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Vext Science's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.21/0.004
=52.50

Vext Science's share price for today is C$0.21.
Vext Science's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.004.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Vext Science EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Vext Science's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Vext Science (XCNQ:VEXT) Business Description

Traded in Other Exchanges
Address
4152 N. 39th Avenue, Phoenix, AZ, USA, 85019
Vext Science Inc provides management, advisory, cultivation, and dispensary services to entities in the medical cannabis field. The company's expertise spans from cultivation through to retail operations. Its revenue sources include management fees, professional services, product sales, equipment leasing and property leasing.
Executives
Caroline Marie-clothilde Williams Director

Vext Science (XCNQ:VEXT) Headlines

No Headlines